<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:37:38Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10360223" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10360223</identifier>
        <datestamp>2023-07-22</datestamp>
        <setSpec>bmcorhl</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Oral Health</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Oral Health</journal-id>
              <journal-title-group>
                <journal-title>BMC Oral Health</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1472-6831</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10360223</article-id>
              <article-id pub-id-type="pmcid">PMC10360223</article-id>
              <article-id pub-id-type="pmc-uid">10360223</article-id>
              <article-id pub-id-type="pmid">37480004</article-id>
              <article-id pub-id-type="publisher-id">3206</article-id>
              <article-id pub-id-type="doi">10.1186/s12903-023-03206-5</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Clinical and biochemical assessment of the effect of topical use of coenzyme Q10 versus topical corticosteroid in management of symptomatic oral lichen planus: randomized controlled clinical trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Abdelsamie</surname>
                    <given-names>Mostafa</given-names>
                  </name>
                  <address>
                    <email>mostafa.abdelsamie@dentistry.cu.edu.eg</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zahran</surname>
                    <given-names>Fat’heya</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hussine</surname>
                    <given-names>Amal A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shaker</surname>
                    <given-names>Olfat</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Al-mahallawi</surname>
                    <given-names>Abdulaziz Mohsen</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.7776.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 9286</institution-id><institution>Oral Medicine, Faculty of Dentistry, </institution><institution>Cairo University, </institution></institution-wrap>Cairo, Egypt </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.7776.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 9286</institution-id><institution>Oral Medicine, Faculty of Dentistry, </institution><institution>Cairo University, </institution></institution-wrap>Cairo, Egypt </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.7776.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 9286</institution-id><institution>Oral Medicine, Faculty of Dentistry, </institution><institution>Cairo University, </institution></institution-wrap>Cairo, Egypt </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7776.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 9286</institution-id><institution>Medical Biochemistry and Molecular Biology, Faculty of Medicine, </institution><institution>Cairo University, </institution></institution-wrap>Cairo, Egypt </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.7776.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 9286</institution-id><institution>Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, </institution><institution>Cairo University, </institution></institution-wrap>Cairo, Egypt </aff>
                <aff id="Aff6"><label>6</label>School of Life and Medical Sciences, University of Hertfordshire Hosted By Global Academic Foundation, New Administrative Capital, Cairo, Egypt </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>7</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>21</day>
                <month>7</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>23</volume>
              <elocation-id>506</elocation-id>
              <history>
                <date date-type="received">
                  <day>6</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>6</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2023</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Oral lichen planus (OLP) is a chronic mucocutaneous immunologically mediated condition that has a great adverse effect on oral functions. Corticosteroids are still the first drugs of choice used in the treatment of OLP; however, they have extensive medical side effects. The present study was carried out to assess the clinical therapeutic effect of the topical use of coenzyme Q10 (coQ10 or ubiquinol) versus topical corticosteroids in the management of symptomatic OLP and to determine whether the effect, if any, was due to the powerful antioxidant activity of coQ10.</p>
                </sec>
                <sec>
                  <title>Subjects and methods</title>
                  <p id="Par2">We performed a randomized, double blinded controlled trial at the Faculty of Dentistry, Cairo University, Egypt. The study was conducted on 34 patients suffering from symptomatic OLP. Patients were randomly divided into two groups: intervention group (I),who received topical CoQ10 in the form of mucoadhesive tablets (40% CoQ10) 3 times daily for one month and control group (II),who received topical corticosteroid (kenacort in Orabase: triamcinolone acetonide 0.1% 5-g adhesive paste – dermapharm), 4 times daily for one month. Patients were evaluated at one-week intervals using the clinical parameters (score) of pain (VAS) and lesion size. Additionally, salivary levels of malondialdehyde (MDA) were detected in both groups before and after treatment using ELISA. All recorded data were analysed using independent t test, ANOVA followed by Bonferroni post hoc test for lesion size and salivary level of MDA data and Mann–Whitney U test and Friedman test for VAS data.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Both groups showed a significant reduction in pain and the size of the lesions (<italic>p</italic> ≤ 0.05) with no statistically significant difference between them (<italic>p</italic> &gt; 0.05), and this clinical improvement was associated with a reduction in the salivary levels of MDA in both groups.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">The topical use of CoQ10 mucoadhesive tablets was as effective as the topical use of triamcinolone acetonide, and its clinical effect was associated with a reduction in the salivary level of MDA.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par5">The study protocol was registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrial.gov">www.clinicaltrial.gov</ext-link> (NCT04091698) and registration date: 17/9/2019.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Oral lichen planus</kwd>
                <kwd>Oxidative stress</kwd>
                <kwd>Corticosteroids</kwd>
                <kwd>Antioxidants</kwd>
                <kwd>CoQ10</kwd>
                <kwd>Malondialdehyde</kwd>
                <kwd>Saliva</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>Cairo University</institution>
                  </funding-source>
                </award-group>
                <open-access>
                  <p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>
                </open-access>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par15">Oral lichen planus (OLP) is a relatively common chronic mucocutaneous inflammatory immune-mediated disease of the oral mucosa [<xref ref-type="bibr" rid="CR28">28</xref>], it affects middle-aged females twice as much as males [<xref ref-type="bibr" rid="CR14">14</xref>], with an estimated general population prevalence of 0.89% [<xref ref-type="bibr" rid="CR28">28</xref>], and has recently been categorized as an oral potentially malignant disorder by the World Health Organization (WHO) [<xref ref-type="bibr" rid="CR60">60</xref>]. It has a variety of clinical forms, which may occur alone or in various combinations [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], where the atrophic and erosive forms are the most severe and are introduced to oral medicine clinics with severe burning sensation affecting different oral functions [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
              <p id="Par16">On the other hand, oral lichenoid lesions (OLLs) are a term used to identify conditions that are clinically and histopathologically similar to OLP but with identifiable, either local or systemic causes such as numerous medications, various dental materials (mercury-containing amalgam restorations), and graft versus host disease (GVHD). Compared to the traditional signs of OLP, OLLs tend to be unilateral with histological examination showing more diffuse lymphocytic infiltration with more eosinophils, plasma cells, and colloid bodies. In addition, it resolves once the cause is removed [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
              <p id="Par17">Multiple factors [<xref ref-type="bibr" rid="CR16">16</xref>] and immunological responses [<xref ref-type="bibr" rid="CR9">9</xref>] are implicated in the pathogenesis of OLP. Among these, oxidative stress (OS) is implicated in both OLP pathogenesis and carcinogenic potential [<xref ref-type="bibr" rid="CR29">29</xref>]. Higher salivary levels of reactive oxygen species (ROS), lipid peroxidation, nitric oxide, and nitrite support this theory [<xref ref-type="bibr" rid="CR33">33</xref>], along with the obvious decrease in total antioxidant activity and an increased level of salivary oxidative markers in OLP patients compared to controls [<xref ref-type="bibr" rid="CR53">53</xref>]. OS is defined as a disruption in the balance of pro-oxidant/antioxidant processes in biological organisms [<xref ref-type="bibr" rid="CR25">25</xref>]. It is produced by an excess of ROS or a breakdown in antioxidant functions. ROS can harm human cells by causing protein, carbohydrate, lipid, and nucleotide damage [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
              <p id="Par18">In OLP lesions, ROS exacerbate inflammatory conditions linked to immunological pathways through the activation of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells), a protein complex that regulates proinflammatory gene transcription, such as interleukin 2 (IL-2), tumor necrosis factor-alpha (TNF-α), MHC class 1 gene, and IL-2 receptor gene [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. TNF-α promotes T-lymphocyte recruitment by upregulating matrix metalloproteinase (MMP), which disrupts basement membrane integrity [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
              <p id="Par19">A variety of treatments are used in the management of OLP [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Among these treatments, corticosteroids are the gold standard treatment for OLP due to their anti-inflammatory and immunomodulatory actions through different mechanisms, including decreased leukocyte exudates into inflamed areas through the inhibition of vasodilation and vascular permeability, repressed transcription of many genes encoding proinflammatory cytokines, including NF-κB, suppressed adhesion molecules expression, such as ICAM-1 and VCAM-1, and regulation of Th1 responses and autoimmunity through their direct effect on T cells with stimulation of IL10 secretion [<xref ref-type="bibr" rid="CR12">12</xref>]. However, the long term use of steroids showed different side effects ranging from atrophy of the oral mucosa or secondary candidiasis, associated with the topical use of corticosteroid therapy [<xref ref-type="bibr" rid="CR31">31</xref>], to more serious systemic side effects, such as hypertension, osteoporosis and adrenal insufficiency, associated with the systemic administration of corticosteroids [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR62">62</xref>], resulting in a continuing search for safer and more effective therapies.</p>
              <p id="Par20">Co enzyme Q10 is a lipid-soluble endogenous antioxidant compound due to its ability to scavenge free radicals such as superoxide anion (O2•), hydrogen peroxide (H2O2) and hydroxyl radical (OH•) [<xref ref-type="bibr" rid="CR7">7</xref>]. It also augments the function of other endogenous antioxidants, such as α-tocopherol (vitamin E) and ascorbate (vitamin C) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. In addition, it enhances other antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase [<xref ref-type="bibr" rid="CR10">10</xref>]. In addition to the antioxidant role of CoQ10, it has an anti-inflammatory role through its suppression to the gene expression of NFκB1 and the overproduction of proinflammatory cytokines such as TNF-α and interleukin-6 [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR18">18</xref>],Furthermore, it promotes the expression of anti-inflammatory cytokines such as IL-10 [<xref ref-type="bibr" rid="CR23">23</xref>], thus promoting tissue regeneration and wound healing [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR61">61</xref>].</p>
            </sec>
            <sec id="Sec2">
              <title>Subjects and methods</title>
              <sec id="Sec3">
                <title>Study design</title>
                <p id="Par21">The present study is a randomized controlled clinical trial (two parallel groups) with an allocation ratio of 1:1. The number of patients was equal in each group. The study was conducted following the principles of the Helsinki Declaration and was approved by the Research Ethics Committee of the Faculty of Dentistry, Cairo University (code: 19923).The protocol was registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrial.gov">www.clinicaltrial.gov</ext-link> (NCT04091698).</p>
              </sec>
              <sec id="Sec4">
                <title>Study participants</title>
                <p id="Par22">The patients were recruited from the Diagnostic Center, as well as the Clinics of the Oral Medicine and Periodontology Department, at the Faculty of Dentistry, Cairo University, during the period from September 2019 to February 2022. According to specific inclusion and exclusion criteria<bold>.</bold>
</p>
              </sec>
              <sec id="Sec5">
                <title>Inclusion criteria</title>
                <p id="Par23">
                  <list list-type="order">
                    <list-item>
                      <p id="Par24">Patients were more than 18 years old.</p>
                    </list-item>
                    <list-item>
                      <p id="Par25">Patients were free from any systemic disease according to the detailed questionnaire of the modified Cornell Medical Index [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
                    </list-item>
                    <list-item>
                      <p id="Par26">Patients clinically diagnosed by a dermatologist and oral medicine specialist as suffering from OLP.</p>
                    </list-item>
                    <list-item>
                      <p id="Par27">Patients who agreed to the biopsy in undiagnosed cases<bold>.</bold>
</p>
                    </list-item>
                    <list-item>
                      <p id="Par28">Clinical and histopathological criteria were used according to modified WHO diagnostic criteria for OLP [<xref ref-type="bibr" rid="CR59">59</xref>].</p>
                    </list-item>
                    <list-item>
                      <p id="Par29">Patients who were willing to participate in this study (who agreed to give informed consent) and had the ability to complete the study.</p>
                    </list-item>
                  </list>
                </p>
              </sec>
              <sec id="Sec6">
                <title>Exclusion criteria</title>
                <p id="Par30">
                  <list list-type="order">
                    <list-item>
                      <p id="Par31">Patients taking systemic drugs such as systemic steroids, or other immunosuppressive therapies for at least 8 weeks prior to the study.</p>
                    </list-item>
                    <list-item>
                      <p id="Par32">Patients treated with any oral topical medications for at least four weeks prior to the study.</p>
                    </list-item>
                    <list-item>
                      <p id="Par33">Patients receiving any medication either topical or systemic that could cause lichenoid reaction during the 3 months before the study.</p>
                    </list-item>
                    <list-item>
                      <p id="Par34">Patients with suspected restoration or drug-related lichenoid lesions.</p>
                    </list-item>
                    <list-item>
                      <p id="Par35">Pregnant and lactating females.
</p>
                    </list-item>
                  </list>
                </p>
              </sec>
              <sec id="Sec7">
                <title>Study interventions</title>
                <p id="Par36">The present study was conducted on 34 patients suffering from symptomatic OLP. Patients were randomly divided into two groups and received both treatments in the form of opaque sealed jars (Jar A) for adhesive tablets (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) and (Jar B) for triamcinolone paste (Fig. <xref rid="Fig3" ref-type="fig">3</xref>):<fig id="Fig1"><label>Fig. 1</label><caption><p>Opaque sealed jar containing mucoadhesive CoQ10 tablets</p></caption><graphic xlink:href="12903_2023_3206_Fig1_HTML" id="MO1"/></fig></p>
                <sec id="Sec8">
                  <title>Group I (intervention group)</title>
                  <p id="Par37">Seventeen participants received topical coenzyme Q10 (ubiquinol) in the form of mucoadhesive tablets, (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), 3 times daily for one month. All patients were instructed to apply slight pressure for 1 min on the entire surface of the tablet using their finger and then let it dissolve without peeling it off. They were also instructed to avoid bringing their teeth into contact with the tablets, to avoid chewing or excessive jaw movements, and to avoid eating or drinking for at least 1 h following application of the tablet [<xref ref-type="bibr" rid="CR11">11</xref>]. They were also instructed to apply the tablet on a single lesion that was the most painful lesion for the patient, and found to be related to the buccal mucosa in most cases.</p>
                </sec>
                <sec id="Sec9">
                  <title>CoQ10 mucoadhesive tablet preparation</title>
                  <p id="Par38">The tablets were prepared using 120 mg coQ10 powder (in reduced form which is the antioxidant form) [<xref ref-type="bibr" rid="CR41">41</xref>], mixed with mucoadhesive polymer 120 mg carbapol [<xref ref-type="bibr" rid="CR42">42</xref>], and 60 mg anhydrous lactose [<xref ref-type="bibr" rid="CR21">21</xref>], using a bench scale powder mixer continuously for 10 min. The components of each tablet were fed manually into a 13 mm die and compressed using a constant compression force to produce tablets (40% coQ10 concentration) with a 13 mm surface area and hardness of 10 kgf (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Mucoadhesive CoQ10 tablets</p></caption><graphic xlink:href="12903_2023_3206_Fig2_HTML" id="MO3"/></fig></p>
                </sec>
                <sec id="Sec10">
                  <title>Group II (control group)</title>
                  <p id="Par39">Seventeen participants received topical corticosteroid (kenacorte in Orabase: triamcinolone acetonide 0.1% 5-g adhesive paste – dermapharm), (Fig. <xref rid="Fig3" ref-type="fig">3</xref>), 4 times daily for one month [<xref ref-type="bibr" rid="CR26">26</xref>]. All patients were instructed to apply a thin layer using a finger or cotton tip applicator, considering not to eat, drink, or speak for at least 1 h. Miconazole 2% topical antifungal (Miconaz® oral gel: Miconazole 2 g per 100 gm) (Medical Union Pharmaceuticals—MUP—Egypt) was applied after a 4 week follow- up period to avoid secondary candidiasis in this group [<xref ref-type="bibr" rid="CR22">22</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>Opaque sealed jar containing triamcinolone acetonide paste</p></caption><graphic xlink:href="12903_2023_3206_Fig3_HTML" id="MO2"/></fig></p>
                </sec>
              </sec>
              <sec id="Sec11">
                <title>Study outcomes</title>
                <p id="Par40">
                  <list list-type="order">
                    <list-item>
                      <p id="Par41">Primary outcome<list list-type="bullet"><list-item><label/><p id="Par42">1.1. Pain measurement using the Visual Analogue Scale: according to Maxwell [<xref ref-type="bibr" rid="CR32">32</xref>]</p></list-item><list-item><label/><p id="Par43">All patients were asked to define their level of pain and discomfort by using a numerical rating from 0 to 10 (11-points), with 0 indicating "no pain", 1 to 3 indicating mild pain, 4 to 6 indicating moderate pain, 7 to 9 indicating sever pain and 10 indicating "extremely painful".</p></list-item><list-item><label/><p id="Par44">1.2. Clinical improvement of the lesion, according to Thongprasom et al. [<xref ref-type="bibr" rid="CR56">56</xref>]<list list-type="bullet"><list-item><label/><p id="Par45"> 0 = no lesion</p></list-item><list-item><label/><p id="Par46"> 1 = white striae only</p></list-item><list-item><label/><p id="Par47">2  = white striae and atrophic ≤ 1 cm<sup>2</sup>
</p></list-item><list-item><label/><p id="Par48">3  = white striae with atrophic &gt; 1 cm<sup>2</sup>
</p></list-item><list-item><label/><p id="Par49"> 4 = white striae with erosion ≤ 1 cm<sup>2</sup>
</p></list-item><list-item><label/><p id="Par50"> 5 = white striae with erosion &gt; 1 cm<sup>2</sup>
</p></list-item></list></p><p id="Par51">The clinical score for each patient was calculated by recording a score for each lesion in the oral cavity separately using a graduated periodontal probe, and then calculating the average of these scores.</p></list-item></list></p>
                    </list-item>
                    <list-item>
                      <p id="Par52">Secondary outcome<list list-type="bullet"><list-item><label/><p id="Par53">2.1. Change in salivary level of malondialdehyde detected at baseline and after treatment (after 4 weeks) using ELISA.</p></list-item><list-item><label/><p id="Par54">2.2. Change in Clinical global impression scale detected from baseline to the end of treatment after 4 weeks, in which the patients rated overall change in OLP symptoms during the treatment period (patient global impression of change; PGI-C), choosing 1 of 7 answers ranging from “very much better” to “very much worse.” 1 = very much better/improved, 2 = much better/improved, 3 = a little better/improved, 4 = no change, 5 = a little worse, 6 = much worse, and 7 = very much worse.</p></list-item></list></p>
                    </list-item>
                  </list>
                </p>
              </sec>
              <sec id="Sec12">
                <title>Saliva sample collection</title>
                <p id="Par55">Whole unstimulated saliva (WUS) was collected between 8 am to 1 pm using standard techniques according to Navazesh [<xref ref-type="bibr" rid="CR37">37</xref>]. At the time of saliva collection, lesions were actively symptomatic, and subjects were asked not to eat, brush their teeth, or use mouth rinse at least 2 h prior to salivary sample collection on that day. Samples were obtained by requesting subjects to swallow first, tilt their heads forward, and expectorate 10 mL of unstimulated whole saliva into a sterile centrifuge tube. After collection, the saliva was immediately centrifuged for 2 min at 10,000 × g and the clarified supernatant was filtered through a 0.45 μm low protein binding membrane, separated into 0.5 mL aliquots and frozen at − 80 ◦C until assayed.</p>
              </sec>
              <sec id="Sec13">
                <title>Determination of human malondialdehyde (MDA) in saliva using an ELISA kit (prepared by Prof. OS)</title>
                <p id="Par56">Saliva samples were centrifuged for 10 min at 4000 xg. The supernatant was separated and used for determination of MDA levels using ELISA Kit Cat No. MBS263626 provided by My BioSource (USA, NY). This kit employs the “Double Antibody Sandwich” technique. The principle of double antibody sandwich is based on the characteristics of a target analytic with more than two possible epitopes that can be identified by both the precoated capture antibody and the detection antibody simultaneously.In this kit, the precoated antibody is an anti-human MDA monoclonal antibody, while the detection antibody is a biotinylated polyclonal antibody. Samples and biotinylated antibodies are added into ELISA plate wells and washed out with PBS or TBS after their respective additions to the wells. Then, avidin-peroxidase conjugates were added to the wells. TMB substrate is used for colouration after the enzyme conjugate has already been thoroughly washed out of the wells by PBS or TBS. TMB reacts to form a blue product from the peroxidase activity, and finally turns yellow after addition of the stop solution (Color Reagent C). The color intensity and quantity of target analytics in the sample are positively correlated [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
              </sec>
              <sec id="Sec14">
                <title>Sample size calculation</title>
                <p id="Par57">An interventional study by Thomas et al. [<xref ref-type="bibr" rid="CR55">55</xref>] was used by medical biostatistics unit members, Faculty of Dentistry, Cairo University, to calculate sample size using an independent t-test. The mean and standard deviation for group 1 = 1.36 ± 1.11 while for group 2 = 2.47 ± 0.841,the alpha level of significance = 0.05, and the power of the study was 0.8.The sample size produced was 28 in both groups and increased by 20% to 34 (17 per group) to compensate for drop-outs.</p>
              </sec>
              <sec id="Sec15">
                <title>Randomization and allocation concealment</title>
                <p id="Par58">Simple randomization was generated using <ext-link ext-link-type="uri" xlink:href="http://www.randomizer.org">www.randomizer.org</ext-link> and performed by the principal investigator. Allocation concealment was performed by placing the treatment assignment in sequentially numbered, opaque, sealed envelopes.</p>
              </sec>
              <sec id="Sec16">
                <title>Masking/blinding</title>
                <p id="Par59">Neither the statistician nor clinical outcome assessor (associate prof. AH) were aware of which medication was being administered, thus yielding a double-blind controlled study.</p>
              </sec>
              <sec id="Sec17">
                <title>Data collection and statistical analysis</title>
                <p id="Par60">All data collected from patients using clinical parameters were recorded electronically for statistical analysis. Categorical data are presented as frequencies (n), and percentages (%), and the chi square test was used for the analysis. Quantitative data were explored for normality using Kolmogorov–Smirnov and Shapiro–Wilk tests and are presented as the mean and standard deviation (SD). Parametric data of age, lesion size and salivary level of MDA were analyzed using independent t test for intergroup comparisons and repeated measures ANOVA followed by Bonferroni post hoc test. VAS data showed a nonparametric distribution so they were analyzed using the Mann -Whitney U test for intergroup comparisons and the Friedman test of repeated measures for intragroup comparisons. When the Friedman test was significant, it was followed by multiple pairwise comparisons utilizing the Wilcoxon signed rank test with Bonferroni correction. The significance level was set at <italic>P</italic> ≤ 0.05 for all tests. Statistical analysis was performed with IBM® SPSS® (SPSS Inc., IBM Corporation, NY, and USA) Statistics Version 26 for Windows.</p>
              </sec>
            </sec>
            <sec id="Sec18">
              <title>Results</title>
              <p id="Par61">During the recruitment phase, 36 patients were assessed for eligibility from September 2019 to February 2022. Two patients did not meet the inclusion criteria due to their chronic systemic diseases. Only thirty-four participants were eligible for inclusion. All patients gave written informed consent and were randomly allocated equally to the intervention group (<italic>n</italic> = 17), who received topical mucoadhesive tablets, and the control group (<italic>n</italic> = 17), who received topical corticosteroids. No participants were excluded during the follow up period (4 weeks) and all participants were analyzed, (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The mean ± SD value of the ages in the intervention group was 35.82 ± 8.36 and for the control group it was 38.41 ± 7.45. There was no significant difference between the ages of the participants in both groups (<italic>P</italic> = 0.348). All the participants in the intervention group were females. In the control group, two (11.8%) of the participants were males, while fifteen (88.2%) were females. There was no significant difference in gender distribution between the groups (<italic>P</italic> = 0.485), (Table <xref rid="Tab1" ref-type="table">1</xref>). Regarding the clinical characteristics of symptomatic OLP lesions, the atrophic form of OLP occurred in 64.7% of the participants in the intervention group and 52.9% of the participants in the control group, while the erosive form of OLP occurred in 35.3% of the participants in the intervention group and 47.1% of the participants in the control group (Table <xref rid="Tab2" ref-type="table">2</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>CONSORT flow diagram of participants</p></caption><graphic xlink:href="12903_2023_3206_Fig4_HTML" id="MO4"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic data of age and gender</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3">Groups</th><th align="left" colspan="4">Gender</th><th align="left" rowspan="3">Age (Mean ± SD)</th></tr><tr><th align="left" colspan="2">Male</th><th align="left" colspan="2">Female</th></tr><tr><th align="left">(n)</th><th align="left">%</th><th align="left">(n)</th><th align="left">%</th></tr></thead><tbody><tr><td align="left">Intervention</td><td align="left">(0)</td><td align="left">0.0%</td><td align="left">(17)</td><td align="left">100.0%</td><td align="left">35.82 ± 8.36</td></tr><tr><td align="left">Control</td><td align="left">(2)</td><td align="left">11.8%</td><td align="left">(15)</td><td align="left">88.2%</td><td align="left">38.41 ± 7.45</td></tr><tr><td align="left"><italic>P</italic>-value</td><td align="left" colspan="4">0.485</td><td align="left">0.348S</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Clinical characteristics of symptomatic OLP lesions in both groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Groups</th><th align="left" colspan="2">Atrophic OLP(n)</th><th align="left" colspan="2">Erosive OLP(n)</th></tr><tr><th align="left">(n)</th><th align="left">%</th><th align="left">(n)</th><th align="left">%</th></tr></thead><tbody><tr><td align="left"><bold>Intervention</bold></td><td align="left">11</td><td align="left">64.7%</td><td align="left">6</td><td align="left">35.3%</td></tr><tr><td align="left"><bold>Control</bold></td><td align="left">9</td><td align="left">52.9%</td><td align="left">8</td><td align="left">47.1%</td></tr></tbody></table></table-wrap></p>
              <p id="Par62">After the 4 week follow up period, both the intervention group and control group showed a significant difference in VAS scores at different follow-up intervals (<italic>p</italic> &lt; 0.001). The highest (mean ± SD) value of VAS was recorded at (week) (7.00 ± 1.06) in the intervention group and (7.41 ± 1.00) in the control group, while the lowest value was found at (4 weeks), which was (2.06 ± 1.92) in the intervention group and (1.94 ± 2.08) in the control group. Pairwise comparisons showed values measured at (week) to be significantly higher than values measured at other intervals except for (2 weeks) (<italic>p</italic> &lt; 0.05) in both groups. Intergroup comparison showed that, at 4 weeks, (the mean ± SD) value of VAS scores in the intervention group was slightly higher, while for other follow-up intervals, the control group was higher; however, the differences did not reach the level of significance (<italic>P</italic> &gt; 0.05) (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Mean and standard deviation (SD) of VAS scores in both groups and different follow-up intervals</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Follow-up intervals</th><th align="left" colspan="2">(VAS) (Mean ± SD)</th><th align="left" rowspan="2"><italic>P</italic>-value</th></tr><tr><th align="left">Intervention</th><th align="left">Control</th></tr></thead><tbody><tr><td align="left">Week</td><td align="left">7.00 ± 1.06<sup>A</sup>
</td><td align="left">7.41 ± 1.00<sup>A</sup>
</td><td align="left">0.222 ns</td></tr><tr><td align="left">2 weeks</td><td align="left">5.18 ± 1.13<sup>AB</sup>
</td><td align="left">5.76 ± 0.90<sup>AB</sup>
</td><td align="left">0.159 ns</td></tr><tr><td align="left">3 weeks</td><td align="left">4.00 ± 1.22<sup>BC</sup>
</td><td align="left">4.06 ± 1.64<sup>BC</sup>
</td><td align="left">0.858 ns</td></tr><tr><td align="left">4 weeks</td><td align="left">2.06 ± 1.92<sup>C</sup>
</td><td align="left">1.94 ± 2.08<sup>C</sup>
</td><td align="left">0.787 ns</td></tr><tr><td align="left"><italic>P</italic>-value</td><td align="left"> &lt; 0.001*</td><td align="left"> &lt; 0.001*</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Different superscript letters within the same column indicate a statistically significant difference*; significant (<italic>p</italic> ≤ 0.05) ns; nonsignificant (<italic>p</italic> &gt; 0.05)</p></table-wrap-foot></table-wrap></p>
              <p id="Par63">Regarding the (mean ± SD) value of lesion size using the (Thongprasom scale), the intervention group showed a significant difference between lesion sizes at different follow-up intervals (<italic>p</italic> &lt; 0.001). The highest (mean ± SD) value of lesion size was recorded at the first week (3.02 ± 0.87), while the lowest value was found at 4 weeks (1.37 ± 0.74). Pairwise comparisons showed that the value measured after one week was significantly higher than the values measured at other intervals except for 2 weeks (<italic>p</italic> &lt; 0.05). In the control group, there was a significant difference between lesion sizes at different follow-up intervals (<italic>p</italic> &lt; 0.001). The highest (mean ± SD) value of lesion size was recorded at week (3.43 ± 0.74), while the lowest value was found at 4 weeks (1.21 ± 0.90). Pairwise comparisons showed that the differences between values of follow-up weeks were all statistically significant (<italic>p</italic> &lt; 0.05). Intergroup comparison showed that, at (3 weeks) and (4 weeks), the (mean ± SD) value of the intervention group was slightly higher than that of the control group, while for other follow-up intervals (week and 2 weeks), the control group was higher. At all follow-up intervals, there was no significant difference between the groups (<italic>P</italic> &gt; 0.05) (Table <xref rid="Tab4" ref-type="table">4</xref> and Fig. <xref rid="Fig5" ref-type="fig">5</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Mean and standard deviation of lesion size in (Thongprasom scale) in both groups and different follow-up intervals</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Follow-up intervals</th><th align="left" colspan="2">Lesion size in thongprasom scale (Mean ± SD)</th><th align="left" rowspan="2"><italic>P</italic>-value</th></tr><tr><th align="left">Intervention</th><th align="left">Control</th></tr></thead><tbody><tr><td align="left">Week</td><td align="left">3.02 ± 0.87<sup>A</sup>
</td><td align="left">3.43 ± 0.74<sup>A</sup>
</td><td align="left">0.148 ns</td></tr><tr><td align="left">2 weeks</td><td align="left">2.64 ± 0.79<sup>AB</sup>
</td><td align="left">2.86 ± 0.79<sup>B</sup>
</td><td align="left">0.410 ns</td></tr><tr><td align="left">3 weeks</td><td align="left">2.18 ± 0.56<sup>B</sup>
</td><td align="left">2.09 ± 0.80<sup>C</sup>
</td><td align="left">0.692 ns</td></tr><tr><td align="left">4 weeks</td><td align="left">1.37 ± 0.74<sup>C</sup>
</td><td align="left">1.21 ± 0.90<sup>D</sup>
</td><td align="left">0.564 ns</td></tr><tr><td align="left"><italic>P</italic>-value</td><td align="left"> &lt; 0.001*</td><td align="left"> &lt; 0.001*</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Different superscript letters within the same column indicate a statistically significant difference*; significant (<italic>p</italic> ≤ 0.05) <italic>ns</italic> nonsignificant (<italic>p</italic> &gt; 0.05)</p></table-wrap-foot></table-wrap><fig id="Fig5"><label>Fig. 5</label><caption><p>Line chart showing average lesion size in (Thongprasom scale) in different follow-up intervals</p></caption><graphic xlink:href="12903_2023_3206_Fig5_HTML" id="MO5"/></fig></p>
              <p id="Par64">In addition to the clinical assessment, the salivary level of malondialdehyde (pg/ml) before and after the treatment in both groups was assessed which showed that the intervention group value of salivary level of malondialdehyde (pg/ml) measured before (7.08 ± 4.46) was higher than value measured after treatment (5.92 ± 2.73), however the difference was not statistically significant (<italic>p</italic> = 0.311). Additionally the control group showed that the salivary level of malondialdehyde (pg/ml) measured before treatment (4.12 ± 2.37) was higher than the value measured after treatment (3.73 ± 2.25) which was not statistically significant (<italic>p</italic> = 0.522). At both intervals, the (mean ± SD) value of the intervention group was significantly higher than that of the control group (<italic>P</italic> &lt; 0.05) (Table <xref rid="Tab5" ref-type="table">5</xref> and Fig. <xref rid="Fig6" ref-type="fig">6</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Mean and standard deviation of salivary level of malondialdehyde (pg/ml) in both groups and different follow-up intervals</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Follow-up intervals</th><th align="left" colspan="2">Salivary level of Malondialdehyde (pg/ml) (Mean ± SD)</th><th align="left" rowspan="2"><italic>P</italic>-value</th></tr><tr><th align="left">Intervention</th><th align="left">Control</th></tr></thead><tbody><tr><td align="left">Before</td><td align="left">7.08 ± 4.46</td><td align="left">4.12 ± 2.37</td><td align="left">0.022*</td></tr><tr><td align="left">After</td><td align="left">5.92 ± 2.73</td><td align="left">3.73 ± 2.25</td><td align="left">0.016*</td></tr><tr><td align="left"><italic>P</italic>-value</td><td align="left">0.311 ns</td><td align="left">0.522 ns</td><td align="left"/></tr></tbody></table><table-wrap-foot><p><italic>ns</italic> nonsignificant (<italic>p</italic> &gt; 0.05)</p></table-wrap-foot></table-wrap><fig id="Fig6"><label>Fig. 6</label><caption><p>Line chart showing the average salivary level of malondialdehyde (pg/ml) at different follow-up intervals</p></caption><graphic xlink:href="12903_2023_3206_Fig6_HTML" id="MO6"/></fig></p>
              <p id="Par65">Finally, PGI-C assessing patient experience with their OLP at end of dosing also showed clinically meaningful improvements in both groups with 12/17 patients (70.5%) in mucoadhesive Coq10 intervention group and 14/17 patients (82.3%) in the control group reporting their OLP feeling much better or very much better.</p>
              <p id="Par66">Regarding drug safety in both groups, none of the participants in either group reported any temporary or permanent adverse effects with either treatment during the 4 week follow up period.</p>
            </sec>
            <sec id="Sec19">
              <title>Discussion</title>
              <p id="Par67">The chronic nature of OLP, prolonged course of treatment, and frequent exacerbation of the condition increase the incidence of steroid side effects [<xref ref-type="bibr" rid="CR15">15</xref>], therefore, the search for new treatment modalities has become essential to overcome the side effects of the long term use of steroids. Among these, antioxidant and anti-inflammatory agents were proposed based on the role that might be played by oxidative stress in the pathogenesis of OLP [<xref ref-type="bibr" rid="CR5">5</xref>] and [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
              <p id="Par68">In addition to the antioxidant and anti-inflammatory effects of CoQ10, its topical use in the form of mucoadhesive tablets in the present study has many advantages including intimate contact with the target mucous membrane, sustained drug release, increased drug absorption, and bioavailability, avoidance of enzymatic degradation in the GIT, and decreased adverse drug effects [<xref ref-type="bibr" rid="CR49">49</xref>]. Additionally, the systemic use of CoQ10 was reported in a few cases to cause mild insomnia, rashes, nausea, and upper abdominal pain [<xref ref-type="bibr" rid="CR39">39</xref>]. In our study, the topical use of CoQ10 prevented the incidence of these side effects.</p>
              <p id="Par69">The mucoadhesiveness of these tablets is gained from the use of mucoadhesive carbapol polymer that rapidly swells when touching the target area, thus providing sustained and controlled release of the drug from 6–8 h, and a strong mucosal adhesion effect [<xref ref-type="bibr" rid="CR42">42</xref>]. Furthermore, its topical use is safe with a nonsensitizing effect and no effect on the biological activity of other drugs [<xref ref-type="bibr" rid="CR40">40</xref>]. Anhydrous lactose was added to these tables to improve taste, with no effect on the biological activity of the drug used [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
              <p id="Par70">Up to our knowledge, the current study is the first randomized control clinical trial evaluating the effectiveness of topical use of CoQ10 in the management of symptomatic OLP. Consequently, no similar previous studies are available for comparison with our results. Shoukheba and Elgendy’s [<xref ref-type="bibr" rid="CR54">54</xref>] study is the only one where CoQ10 was tried for the management of OLP, but in the systemic form of 30 mg CoQ10 capsules, combined with topical corticosteroid.</p>
              <p id="Par71">The results of the current study showed that the topical use of CoQ10 mucoadhesive tablets significantly reduced both pain sensation and clinical signs with maximum clinical improvement at the fourth week and no significant differences when compared with the results of topical corticosteroid. The effective role of the topical use of CoQ10 was also seen in the study conducted by Shoukheba and Elgendy [<xref ref-type="bibr" rid="CR54">54</xref>], who reported that the systemic use of CoQ10 in combination with topical corticosteroids improved the condition more than the topical use of corticosteroids alone.</p>
              <p id="Par72">In addition to the clinical assessment, the salivary levels of MDA in both groups decreased after treatment with no significant difference. Therefore, we could assume that the clinical improvement in both groups might be due to the anti-inflammatory effect of both corticosteroids [<xref ref-type="bibr" rid="CR12">12</xref>] and CoQ10 [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], which directly have a great effect on decreasing the secretion of proinflammatory cytokines such as TNF-α and subsequently, oxidative stress damage [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p>
              <p id="Par73">However, it is expected that corticosteroids would have a more potent anti-inflammatory effect than CoQ10. Thus, it seems that while the decrease in oxidative stress in the case of triamcinolone could be totally a result, in the case of CoQ10, it is partly a result and partly due to the powerful antioxidant role of CoQ10 which was previously detected by Ushikoshi-Nakayama et al. [<xref ref-type="bibr" rid="CR58">58</xref>]. This double action of CoQ10 could be the reason for its effect being equivalent to that of triamcinolone.</p>
              <p id="Par74">Topical CoQ10 has been previously investigated in other oral conditions, such as periodontal and gingival conditions, and showed a great clinical reduction in the inflammatory condition after a few weeks [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>].</p>
              <p id="Par75">Comparing our study with other studies using antioxidant agents in the management of OLP, such as selenium -ACE [<xref ref-type="bibr" rid="CR6">6</xref>], selenium [<xref ref-type="bibr" rid="CR46">46</xref>], Aloe vera (AV) [<xref ref-type="bibr" rid="CR1">1</xref>], curcumin [<xref ref-type="bibr" rid="CR47">47</xref>], lycopene [<xref ref-type="bibr" rid="CR50">50</xref>], quercetin [<xref ref-type="bibr" rid="CR3">3</xref>] and ozone therapy [<xref ref-type="bibr" rid="CR34">34</xref>],we can deduce that, coQ10 can be used as an alternative treatment or in combination with corticosteroids for OLP management, similar to other antioxidants, excluding quercetin which did not show any significant difference when added to topical corticosteroids compared with the placebo treatment [<xref ref-type="bibr" rid="CR3">3</xref>]. In addition, coQ10 was sufficient to improve the oral condition clinically when taken in daily small doses for a short period (4 weeks), unlike curcumin, which improved the oral condition after being taken in large amounts for a long period [<xref ref-type="bibr" rid="CR47">47</xref>]. Only a few studies have measured salivary MDA levels, including selenium [<xref ref-type="bibr" rid="CR46">46</xref>], and curcumin [<xref ref-type="bibr" rid="CR47">47</xref>], which showed the antioxidant effect of systemic use of selenium and curcumin, as seen with the topical use of coQ10 in our study. The study was limited by the short follow-up, precluding the opportunity to evaluate the relapse rate and the effect of topical use of CoQ10 when used for a long duration. Furthermore, the small sample size recommended the need for more clinical trials to conclude the effective role of CoQ10 in the management of symptomatic OLP.</p>
            </sec>
            <sec id="Sec20">
              <title>Conclusions</title>
              <p id="Par76">
                <list list-type="order">
                  <list-item>
                    <p id="Par77">Topical application of mucoadhesive CoQ10 tablets on symptomatic OLP lesions leads to significant pain relief and clinical improvement of the condition in addition to decreasing the salivary levels of one of the markers of oxidative stress (MDA).</p>
                  </list-item>
                  <list-item>
                    <p id="Par78">CoQ10 in a mucoadhesive formula is as effective as the standard treatment triamcinolone acetonide in reducing pain scores and lesion size in OLP<bold>.</bold>
</p>
                  </list-item>
                  <list-item>
                    <p id="Par79">Topical CoQ10 as an antioxidant and anti-inflammatory agent together with its analgesic effect is a safe treatment modality for symptomatic OLP, with no apparent side effects<bold>.</bold>
</p>
                  </list-item>
                </list>
              </p>
            </sec>
            <sec id="Sec21">
              <title>Recommendations</title>
              <p id="Par80">
                <list list-type="order">
                  <list-item>
                    <p id="Par81">Studies with larger sample sizes are needed to conclude the effective role of CoQ10 in the management of symptomatic OLP.</p>
                  </list-item>
                  <list-item>
                    <p id="Par82">Different concentrations of CoQ10 need to be used to reach the optimum dose required to achieve optimum management of OLP with no side effects.</p>
                  </list-item>
                  <list-item>
                    <p id="Par83">The period between lesion remission and exacerbation for CoQ10 should be measured.</p>
                  </list-item>
                  <list-item>
                    <p id="Par84">Evaluation of CoQ10 use for a long duration is also needed.</p>
                  </list-item>
                </list>
              </p>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>OLP</term>
                  <def>
                    <p id="Par6">Oral lichen planus</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CoQ10</term>
                  <def>
                    <p id="Par7">Co enzyme Q10</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ROS</term>
                  <def>
                    <p id="Par8">Reactive oxygen species</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TNF-α</term>
                  <def>
                    <p id="Par9">Tumor necrosis factor-alpha</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NF-Kb</term>
                  <def>
                    <p id="Par10">Nuclear factor kappa-light-chain-enhancer of activated B cells</p>
                  </def>
                </def-item>
                <def-item>
                  <term>OS</term>
                  <def>
                    <p id="Par11">Oxidative stress</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ICAM</term>
                  <def>
                    <p id="Par12">Intercellular adhesion molecule</p>
                  </def>
                </def-item>
                <def-item>
                  <term>VCAMs</term>
                  <def>
                    <p id="Par13">Vascular adhesion molecules</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MDA</term>
                  <def>
                    <p id="Par14">Malondialdehyde</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>The authors of the study would like to express the greatest thanks to all the staff members of the Oral Medicine Department, Faculty of Dentistry, and Cairo University for their cooperation, kind feelings and for sparing no effort in helping us, as well as many thanks to Mepaco_Arab Co. For Pharmaceuticals and Medicine for supplying us with the powder of Co enzyme Q10 .Finally, we would like to express a lot of thanks to all patients who participated in the study.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>M.A. responsible for the funding and undergoing the clinical and theoretical work of the trial, collecting data, clarification, conclusions and drafting the manuscript. F.Z. responsible for patients’ randomization, providing guidance through the clinical work, revising the theoretical part and help with the conclusions and completion of the data. A.H. responsible for clinical assessment of patients, cases selection, clinical diagnosis as well as help in writing the manuscript. O.S. responsible for Biochemical assessment of salivary samples using enzyme-linked immunosorbent assay (ELISA), interpretation of results and drawing conclusions. A.A. responsible for Coenzyme Q10 mucoadhesive tablets preparation. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). Self-funded.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The datasets used and/or analyzed during the current study are not publicly available due [for better patient data confidentiality] but are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par85">The study was conducted following the principles of the Helsinki Declaration and was approved by the Research Ethics Committee of the Faculty of Dentistry, Cairo University (code: 19923). All patients were informed about the nature and objectives of the study. All participants read, approved, and signed a written informed consent form that was reviewed by the ethics committee of scientific research – Faculty of Dentistry– Cairo University.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par86">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par87">The authors declare no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Gadalla</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Elmeadawy</surname>
                      <given-names>SH</given-names>
                    </name>
                    <name>
                      <surname>Badria</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>The efficacy of Aloe vera gel in treatment of oral lichen planus</article-title>
                  <source>Int Dent Med J Adv Res</source>
                  <year>2018</year>
                  <volume>4</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>6</lpage>
                  <pub-id pub-id-type="doi">10.15713/ins.idmjar.85</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aly</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Shahin</surname>
                      <given-names>RS</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxidative stress in lichen planus</article-title>
                  <source>Acta Dermatoven, APA</source>
                  <year>2010</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>3</fpage>
                  <lpage>11</lpage>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Amirchaghmaghi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Delavarian</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Iranshahi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Taghi Shakeri</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mozafari</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Mohammadpour</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Farazi</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Iranshahy</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>A randomized placebo-controlled double blind clinical trial of quercetin for treatment of oral lichen planus</article-title>
                  <source>J Dent Res Dent Clin Dent Prospect</source>
                  <year>2015</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>23</fpage>
                  <lpage>28</lpage>
                  <pub-id pub-id-type="doi">10.15171/joddd.2015.005</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Banerjee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mukherjee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mitra</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Singhal</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative Evaluation of Mitochondrial Antioxidants in Oral Potentially Malignant Disorders</article-title>
                  <source>Kurume Med J</source>
                  <year>2020</year>
                  <volume>66</volume>
                  <issue>1</issue>
                  <fpage>15</fpage>
                  <lpage>27</lpage>
                  <pub-id pub-id-type="doi">10.2739/kurumemedj.MS661009</pub-id>
                  <?supplied-pmid 32378537?>
                  <pub-id pub-id-type="pmid">32378537</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Batu</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ofluoglu</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Ergun</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Warnakulasuriya</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Uslu</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Guven</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Tanyeri</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions</article-title>
                  <source>J Oral Pathol Med</source>
                  <year>2016</year>
                  <volume>45</volume>
                  <fpage>281</fpage>
                  <lpage>288</lpage>
                  <pub-id pub-id-type="doi">10.1111/jop.12391</pub-id>
                  <?supplied-pmid 26661727?>
                  <pub-id pub-id-type="pmid">26661727</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Belal</surname>
                      <given-names>MH</given-names>
                    </name>
                  </person-group>
                  <article-title>Management of symptomatic erosive-ulcerative lesions of oral lichen planus in an adult Egyptian population using Selenium-ACE combined with topical corticosteroids plus antifungal agent</article-title>
                  <source>Contemporary clinical dentistry</source>
                  <year>2015</year>
                  <volume>6</volume>
                  <issue>4</issue>
                  <fpage>454</fpage>
                  <lpage>460</lpage>
                  <pub-id pub-id-type="doi">10.4103/0976-237X.169837</pub-id>
                  <?supplied-pmid 26681847?>
                  <pub-id pub-id-type="pmid">26681847</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bergamini</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Moruzzi</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Sblendido</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lenaz</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fato</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells</article-title>
                  <source>PLoS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <fpage>e33712</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0033712</pub-id>
                  <?supplied-pmid 22432044?>
                  <pub-id pub-id-type="pmid">22432044</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bessler</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Bergman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Blumberger</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Coenzyme Q10 decreases TNF- alpha and IL-2 secretion by human peripheral blood mononuclear cells</article-title>
                  <source>J Nutr Sci Vitaminol</source>
                  <year>2010</year>
                  <volume>56</volume>
                  <fpage>77</fpage>
                  <lpage>81</lpage>
                  <pub-id pub-id-type="doi">10.3177/jnsv.56.77</pub-id>
                  <?supplied-pmid 20354351?>
                  <pub-id pub-id-type="pmid">20354351</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chitturi</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Devy</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Nirmal</surname>
                      <given-names>RM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oral lichen planus: a review of etiopathogenesis, clin ical, histological and treatment aspects</article-title>
                  <source>J Interdiscipl Med Dent Sci</source>
                  <year>2014</year>
                  <volume>2</volume>
                  <fpage>142</fpage>
                  <pub-id pub-id-type="doi">10.4172/2376-032X.1000142</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cirilli</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Damiani</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Dludla</surname>
                      <given-names>PV</given-names>
                    </name>
                    <name>
                      <surname>Hargreaves</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Marcheggiani</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Millichap</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Tiano</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of coenzyme Q10 in health and disease: An update on the last 10 years (2010–2020)</article-title>
                  <source>Antioxidants</source>
                  <year>2021</year>
                  <volume>10</volume>
                  <issue>8</issue>
                  <fpage>1325</fpage>
                  <pub-id pub-id-type="doi">10.3390/antiox10081325</pub-id>
                  <?supplied-pmid 34439573?>
                  <pub-id pub-id-type="pmid">34439573</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Colley</surname>
                      <given-names>HE</given-names>
                    </name>
                    <name>
                      <surname>Said</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Santocildes-Romero</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>D’Apice</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hansen</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Novel bilayer mucoadhesive patches for delivery of clobetasol-17-propionate to the oral mucosa to treat oral lichen planus; an in vitro and in vivo evaluation</article-title>
                  <source>Oral Surg Oral Med Oral Pathol Oral Radiol.</source>
                  <year>2018</year>
                  <volume>126</volume>
                  <fpage>e204</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.06.009</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coutinho</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>KE</given-names>
                    </name>
                  </person-group>
                  <article-title>The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights</article-title>
                  <source>Mol Cell Endocrinol</source>
                  <year>2011</year>
                  <volume>335</volume>
                  <issue>1</issue>
                  <fpage>2</fpage>
                  <lpage>13</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mce.2010.04.005</pub-id>
                  <?supplied-pmid 20398732?>
                  <pub-id pub-id-type="pmid">20398732</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Darweesh</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>El-Sharkawy</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Fadhil</surname>
                      <given-names>ON</given-names>
                    </name>
                    <name>
                      <surname>Maria</surname>
                      <given-names>OM</given-names>
                    </name>
                  </person-group>
                  <article-title>Doxycycline and coenzyme Q10 treatment modalities for chronic periodontitis: a preliminary study</article-title>
                  <source>Int J Oral Dent Health</source>
                  <year>2015</year>
                  <volume>1</volume>
                  <fpage>3</fpage>
                  <pub-id pub-id-type="doi">10.23937/2469-5734/1510014</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Lima</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>de Arruda</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <article-title>Abreu LG et al Clinicopathologic data of individuals with oral lichen planus: a Brazilian case series</article-title>
                  <source>J Clin Exp Dent</source>
                  <year>2019</year>
                  <volume>11</volume>
                  <fpage>e1109</fpage>
                  <lpage>e1119</lpage>
                  <pub-id pub-id-type="doi">10.4317/jced.56379</pub-id>
                  <?supplied-pmid 31824590?>
                  <pub-id pub-id-type="pmid">31824590</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Eisen</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Carrozzo</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bagan Sebastian</surname>
                      <given-names>JV</given-names>
                    </name>
                    <name>
                      <surname>Thongprasom</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Number V Oral lichen planus: clinical features and management</article-title>
                  <source>Oral Dis</source>
                  <year>2005</year>
                  <volume>11</volume>
                  <issue>6</issue>
                  <fpage>338</fpage>
                  <lpage>349</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1601-0825.2005.01142.x</pub-id>
                  <?supplied-pmid 16269024?>
                  <pub-id pub-id-type="pmid">16269024</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <mixed-citation publication-type="other">Elenbaas A, Enciso R, Al-Eryani K. Oral lichen planus: a review of clinical features, etiologies, and treatments. Dentistry Review, 2021: 10.1016/j.dentre.2021.100007</mixed-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <mixed-citation publication-type="other">Farmer EE, Davoine C, 2007. <ext-link ext-link-type="uri" xlink:href="https://www.mybiosource.com/human-elisa-kits/malondialdehyde-mda/263626">https://www.mybiosource.com/human-elisa-kits/malondialdehyde-mda/263626</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <mixed-citation publication-type="other">Farsi F, Heshmati J, Keshtkar A, Irandoost P, Alamdari NM, Akbari A, …,Vafa M. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res Off J Ital. Pharmacol. Soc. 2019, 148, 104290. 10.1016/j.phrs.2019.104290.</mixed-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fouad</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Al-Mulhim</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Jresat</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats</article-title>
                  <source>Environ Toxicol Pharmacol</source>
                  <year>2013</year>
                  <volume>35</volume>
                  <fpage>100</fpage>
                  <lpage>108</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.etap.2012.11.016</pub-id>
                  <?supplied-pmid 23274416?>
                  <pub-id pub-id-type="pmid">23274416</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gorouhi</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Davari</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Fazel</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis</article-title>
                  <source>Sci World J</source>
                  <year>2014</year>
                  <pub-id pub-id-type="doi">10.1155/2014/742826</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guo</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Lactose in pharmaceutical applications</article-title>
                  <source>Drug Del Technol</source>
                  <year>2004</year>
                  <volume>4</volume>
                  <fpage>7</fpage>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <mixed-citation publication-type="other">Hettiarachchi PVKS, Hettiarachchi RM, Jayasinghe RD, Sitheeque M.Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: a double-blinded, randomized clinical trial in Sri Lanka. J Investig Clin Dent. 2017: 8(4). 10.1111/jicd.12237.</mixed-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jin</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Xue</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>ZY</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of coenzyme Q10 on the expression of tumor necrosis factor-α and interleukin-10 in gingival tissue of experimental periodontitis in rats</article-title>
                  <source>Zhonghua Kou Qiang Yi Xue Za Zhi</source>
                  <year>2013</year>
                  <volume>48</volume>
                  <fpage>660</fpage>
                  <lpage>663</lpage>
                  <?supplied-pmid 24513070?>
                  <pub-id pub-id-type="pmid">24513070</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kamath</surname>
                      <given-names>VV</given-names>
                    </name>
                    <name>
                      <surname>Setlu</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Yerlagudda</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral lichenoid lesions-a review and update</article-title>
                  <source>Indian J Dermatol</source>
                  <year>2015</year>
                  <volume>60</volume>
                  <issue>1</issue>
                  <fpage>102</fpage>
                  <pub-id pub-id-type="doi">10.4103/0019-5154.147830</pub-id>
                  <?supplied-pmid 25657414?>
                  <pub-id pub-id-type="pmid">25657414</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kesarwala</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Krishna</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>JB</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxidative stress in oral diseases</article-title>
                  <source>Oral Dis</source>
                  <year>2016</year>
                  <volume>22</volume>
                  <issue>1</issue>
                  <fpage>9</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1111/odi.12300</pub-id>
                  <?supplied-pmid 25417961?>
                  <pub-id pub-id-type="pmid">25417961</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lavaee</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Shadmanpour</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of the effect of photodynamic therapy and topical corticosteroid on oral lichen planus lesions</article-title>
                  <source>Oral Dis</source>
                  <year>2019</year>
                  <volume>25</volume>
                  <issue>8</issue>
                  <fpage>1954</fpage>
                  <lpage>1963</lpage>
                  <pub-id pub-id-type="doi">10.1111/odi.13188</pub-id>
                  <?supplied-pmid 31478283?>
                  <pub-id pub-id-type="pmid">31478283</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lavany</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Jayanthi</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>UK</given-names>
                    </name>
                    <name>
                      <surname>Ranganathan</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral lichen planus: An update on pathogenesis and treatment</article-title>
                  <source>J Oral Maxillofac Pathol</source>
                  <year>2011</year>
                  <volume>15</volume>
                  <issue>2</issue>
                  <fpage>127</fpage>
                  <pub-id pub-id-type="doi">10.4103/0973-029X.84474</pub-id>
                  <pub-id pub-id-type="pmid">22529568</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>X</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Global prevalence and incidence estimates of oral lichen planus: a systematic review and meta-analysis</article-title>
                  <source>JAMA Dermatol</source>
                  <year>2020</year>
                  <volume>156</volume>
                  <issue>2</issue>
                  <fpage>172</fpage>
                  <lpage>181</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamadermatol.2019.3797</pub-id>
                  <?supplied-pmid 31895418?>
                  <pub-id pub-id-type="pmid">31895418</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <mixed-citation publication-type="other">Li X, Wang Z. Mechanisms of reactive oxygen species in oral lichen planus: a literature review. European Journal of Inflammation, 2022: 20. 10.1177/1721727X221104389.</mixed-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lugrin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rosenblatt-Velin</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Parapanov</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The role of oxidative stress during inflammatory processes</article-title>
                  <source>Biol Chem</source>
                  <year>2014</year>
                  <volume>395</volume>
                  <fpage>203</fpage>
                  <lpage>230</lpage>
                  <pub-id pub-id-type="doi">10.1515/hsz-2013-0241</pub-id>
                  <?supplied-pmid 24127541?>
                  <pub-id pub-id-type="pmid">24127541</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marable</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Bowers</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Stout</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Berg</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Sankar</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Brennan</surname>
                      <given-names>MT</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral candidiasis following steroid therapy for oral lichen planus</article-title>
                  <source>Oral Dis</source>
                  <year>2016</year>
                  <volume>22</volume>
                  <issue>2</issue>
                  <fpage>140</fpage>
                  <lpage>147</lpage>
                  <pub-id pub-id-type="doi">10.1111/odi.12399</pub-id>
                  <?supplied-pmid 26599999?>
                  <pub-id pub-id-type="pmid">26599999</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maxwell</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Sensitivity and accuracy of the visual analogue scale: a psychophysical classroom experiment</article-title>
                  <source>Br J Clin Pharmacol</source>
                  <year>1978</year>
                  <volume>6</volume>
                  <fpage>15</fpage>
                  <lpage>24</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1365-2125.1978.tb01676.x</pub-id>
                  <?supplied-pmid 666944?>
                  <pub-id pub-id-type="pmid">666944</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mehdipour</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Taghavi Zenouz</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Dastanpour</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bahramian</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gholizadeh</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Azari-Marhabi</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of serum malondialdehyde level in patients with oral lichen planus</article-title>
                  <source>Caspian J Dent Res.</source>
                  <year>2017</year>
                  <volume>6</volume>
                  <fpage>45</fpage>
                  <lpage>48</lpage>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mostafa</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Zakaria</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of combined topical ozone and steroid therapy in management of oral lichen planus</article-title>
                  <source>Open Access Maced J Med Sci</source>
                  <year>2018</year>
                  <volume>6</volume>
                  <issue>5</issue>
                  <fpage>879</fpage>
                  <lpage>884</lpage>
                  <pub-id pub-id-type="doi">10.3889/oamjms.2018.219</pub-id>
                  <?supplied-pmid 29875865?>
                  <pub-id pub-id-type="pmid">29875865</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Naik</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Dixit</surname>
                      <given-names>VM</given-names>
                    </name>
                  </person-group>
                  <article-title>Mitochondrial reactive oxygen species drive proinflammatory cytokine production</article-title>
                  <source>J Exp Med</source>
                  <year>2011</year>
                  <volume>208</volume>
                  <fpage>417</fpage>
                  <lpage>420</lpage>
                  <pub-id pub-id-type="doi">10.1084/jem.20110367</pub-id>
                  <?supplied-pmid 21357740?>
                  <pub-id pub-id-type="pmid">21357740</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Navas</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Villalba</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>de Cabo</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>The importance of plasma membrane coenzyme Q in aging and stress responses</article-title>
                  <source>Mitochondrion</source>
                  <year>2007</year>
                  <volume>7</volume>
                  <issue>Suppl</issue>
                  <fpage>S34</fpage>
                  <lpage>40</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mito.2007.02.010</pub-id>
                  <?supplied-pmid 17482527?>
                  <pub-id pub-id-type="pmid">17482527</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Navazesh</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Methods for collecting saliva</article-title>
                  <source>Ann N Y Acad Sci</source>
                  <year>1993</year>
                  <volume>694</volume>
                  <fpage>72</fpage>
                  <lpage>77</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1749-6632.1993.tb18343.x</pub-id>
                  <?supplied-pmid 8215087?>
                  <pub-id pub-id-type="pmid">8215087</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Osipoff</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Carpenter</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Noll</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Valdez</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Gormsen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Brennan</surname>
                      <given-names>MT</given-names>
                    </name>
                  </person-group>
                  <article-title>Predictors of symptomatic oral lichen planus</article-title>
                  <source>Oral Surg Oral Med Oral Pathol Oral Radiol</source>
                  <year>2020</year>
                  <volume>129</volume>
                  <fpage>468</fpage>
                  <lpage>477</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.oooo.2019.12.019</pub-id>
                  <?supplied-pmid 32044267?>
                  <pub-id pub-id-type="pmid">32044267</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pahari</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Ghosh</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Halder</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Jana</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of Coenzyme Q10 in human life</article-title>
                  <source>Res J Pharm Technol</source>
                  <year>2016</year>
                  <volume>9</volume>
                  <issue>6</issue>
                  <fpage>635</fpage>
                  <lpage>640</lpage>
                  <pub-id pub-id-type="doi">10.5958/0974-360X.2016.00121.9</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Panzade</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Puranik</surname>
                      <given-names>PK</given-names>
                    </name>
                  </person-group>
                  <article-title>Carbopol polymers: a versatile polymer for pharmaceutical applications</article-title>
                  <source>Res J Pharm Technol</source>
                  <year>2010</year>
                  <volume>3</volume>
                  <issue>3</issue>
                  <fpage>672</fpage>
                  <lpage>675</lpage>
                  <pub-id pub-id-type="doi">10.5958/0974-360X</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Papucci</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Schiavone</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Witort</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Donnini</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lapucci</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Tempestini</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Formigli</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Zecchi-Orlandini</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Orlandini</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Carella</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Brancato</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Capaccioli</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property</article-title>
                  <source>J Biol Chem</source>
                  <year>2003</year>
                  <volume>278</volume>
                  <fpage>28220</fpage>
                  <lpage>28228</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M302297200</pub-id>
                  <?supplied-pmid 12736273?>
                  <pub-id pub-id-type="pmid">12736273</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Paul</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Adimoolam</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Qureshi</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Development and evaluation of metronidazole loaded carbopol 934P mucoadhesive microcapsules for sustained drug release at the gastric mucosa</article-title>
                  <source>J Appl Pharm Sci</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <issue>12</issue>
                  <fpage>020</fpage>
                  <lpage>031</lpage>
                  <pub-id pub-id-type="doi">10.7324/JAPS.2018.81203</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pendleton</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Concordance of Cornell medical index self-reports to structured clinical assessment for the identification of physical health status</article-title>
                  <source>Arch Gerontol Geriatr</source>
                  <year>2004</year>
                  <volume>38</volume>
                  <issue>3</issue>
                  <fpage>261</fpage>
                  <lpage>269</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.archger.2003.10.005</pub-id>
                  <?supplied-pmid 15066312?>
                  <pub-id pub-id-type="pmid">15066312</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Prakash</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sunitha</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hans</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of coenzyme Q 10 as an antioxidant and bioenergizer in periodontal diseases</article-title>
                  <source>Indian J Pharmacol</source>
                  <year>2010</year>
                  <volume>42</volume>
                  <fpage>334</fpage>
                  <lpage>337</lpage>
                  <pub-id pub-id-type="doi">10.4103/0253-7613.71884</pub-id>
                  <?supplied-pmid 21189900?>
                  <pub-id pub-id-type="pmid">21189900</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pranam</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Palwankar</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Pandey</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Goyal</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of Efficacy of Coenzyme Q10 as an Adjunct to Nonsurgical Periodontal Therapy and Its Effect on Crevicular Superoxide Dismutase in Patients with Chronic Periodontitis</article-title>
                  <source>Eur J Dent</source>
                  <year>2020</year>
                  <volume>14</volume>
                  <issue>04</issue>
                  <fpage>551</fpage>
                  <lpage>557</lpage>
                  <pub-id pub-id-type="doi">10.1055/s-0040-1716596</pub-id>
                  <?supplied-pmid 32961568?>
                  <pub-id pub-id-type="pmid">32961568</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Qataya</surname>
                      <given-names>PO</given-names>
                    </name>
                    <name>
                      <surname>Elsayed</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>Elguindy</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>Ahmed Hafiz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Samy</surname>
                      <given-names>WM</given-names>
                    </name>
                  </person-group>
                  <article-title>Selenium: A sole treatment for erosive oral lichen planus (Randomized controlled clinical trial)</article-title>
                  <source>Oral Dis</source>
                  <year>2020</year>
                  <volume>26</volume>
                  <issue>4</issue>
                  <fpage>789</fpage>
                  <lpage>804</lpage>
                  <pub-id pub-id-type="doi">10.1111/odi.13285</pub-id>
                  <?supplied-pmid 31975475?>
                  <pub-id pub-id-type="pmid">31975475</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rai</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kaur</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Jacobs</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Possible action mechanism for curcumin in precancerous lesions based on serum and salivary markers of oxidative stress</article-title>
                  <source>J Oral Sci</source>
                  <year>2010</year>
                  <volume>52</volume>
                  <issue>2</issue>
                  <fpage>251</fpage>
                  <lpage>256</lpage>
                  <pub-id pub-id-type="doi">10.2334/josnusd.52.251</pub-id>
                  <?supplied-pmid 20587949?>
                  <pub-id pub-id-type="pmid">20587949</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Raut</surname>
                      <given-names>CP</given-names>
                    </name>
                    <name>
                      <surname>Sethi</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Kohale</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Mamajiwala</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Warang</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Subgingivally delivered coenzyme Q10 in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical study</article-title>
                  <source>J Oral Biol Craniofac Res</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <issue>2</issue>
                  <fpage>204</fpage>
                  <lpage>208</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jobcr.2018.05.005</pub-id>
                  <?supplied-pmid 31211037?>
                  <pub-id pub-id-type="pmid">31211037</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reddy</surname>
                      <given-names>BV</given-names>
                    </name>
                    <name>
                      <surname>Reddy</surname>
                      <given-names>RK</given-names>
                    </name>
                  </person-group>
                  <article-title>Formulation and evaluation of buccal mucoadhesive tablets of glipizide</article-title>
                  <source>World J Pharm Pharm Sci</source>
                  <year>2015</year>
                  <volume>4</volume>
                  <issue>07</issue>
                  <fpage>1804</fpage>
                  <lpage>1821</lpage>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saawarn</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Shashikanth</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Saawarn</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Jirge</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Chaitanya</surname>
                      <given-names>NC</given-names>
                    </name>
                    <name>
                      <surname>Pinakapani</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Lycopene in the management of oral lichen planus: a placebo-controlled study</article-title>
                  <source>Indian J Dent Res</source>
                  <year>2011</year>
                  <volume>22</volume>
                  <issue>5</issue>
                  <fpage>639</fpage>
                  <pub-id pub-id-type="doi">10.4103/0970-9290.93448</pub-id>
                  <?supplied-pmid 22406705?>
                  <pub-id pub-id-type="pmid">22406705</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schmelzer</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Lindner</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Rimbach</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Niklowitz</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Menke</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Döring</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Functions of coenzyme Q 10 in inflammation and gene expression</article-title>
                  <source>BioFactors</source>
                  <year>2008</year>
                  <volume>32</volume>
                  <fpage>179</fpage>
                  <lpage>183</lpage>
                  <pub-id pub-id-type="doi">10.1002/biof.5520320121</pub-id>
                  <?supplied-pmid 19096114?>
                  <pub-id pub-id-type="pmid">19096114</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shen</surname>
                      <given-names>ZY</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>LK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A retrospective clinicopathological study on oral lichen planus and malignant transformation analysis of 518 cases</article-title>
                  <source>Med Oral Patol Oral Cir Bucal</source>
                  <year>2012</year>
                  <volume>17</volume>
                  <fpage>e943</fpage>
                  <lpage>e947</lpage>
                  <pub-id pub-id-type="doi">10.4317/medoral.17778</pub-id>
                  <?supplied-pmid 22549677?>
                  <pub-id pub-id-type="pmid">22549677</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shiva</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Arab</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of uric acid, total antioxidant and lipid peroxidation parameters in serum and saliva of patients with oral lichen planus</article-title>
                  <source>Glob J Health Sci</source>
                  <year>2016</year>
                  <volume>8</volume>
                  <fpage>225</fpage>
                  <lpage>231</lpage>
                  <pub-id pub-id-type="doi">10.5539/gjhs.v8n12p225</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shoukheba</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Elgendy</surname>
                      <given-names>EA</given-names>
                    </name>
                  </person-group>
                  <article-title>Coenzyme Q10 as a dietary supplement combined with topical corticosteroids in the treatment of erosive lesions of oral lichen planus</article-title>
                  <source>Tanta Dent J</source>
                  <year>2016</year>
                  <volume>13</volume>
                  <issue>3</issue>
                  <fpage>133</fpage>
                  <pub-id pub-id-type="doi">10.4103/1687-8574.191436</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thomas</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Varma</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kurup</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluation of Efficacy of 1% Curcuminoids as Local Application in Management of Oral Lichen Planus - Interventional Study</article-title>
                  <source>J Clin Diagn Res</source>
                  <year>2017</year>
                  <volume>11</volume>
                  <issue>4</issue>
                  <fpage>89</fpage>
                  <lpage>93</lpage>
                  <pub-id pub-id-type="doi">10.7860/JCDR/2017/20898.9715</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thongprasom</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Luangjarmekorn</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Sererat</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Taweesap</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus</article-title>
                  <source>J Oral Pathol Med</source>
                  <year>1992</year>
                  <volume>21</volume>
                  <fpage>456</fpage>
                  <lpage>458</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1600-0714.1992.tb00974.x</pub-id>
                  <?supplied-pmid 1460584?>
                  <pub-id pub-id-type="pmid">1460584</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tippairote</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Bjørklund</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Gasmi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Semenova</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Peana</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Chirumbolo</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hangan</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Combined Supplementation of Coenzyme Q10 and Other Nutrients in Specific Medical Conditions</article-title>
                  <source>Nutrients</source>
                  <year>2022</year>
                  <volume>14</volume>
                  <issue>20</issue>
                  <fpage>4383</fpage>
                  <pub-id pub-id-type="doi">10.3390/nu14204383</pub-id>
                  <?supplied-pmid 36297067?>
                  <pub-id pub-id-type="pmid">36297067</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ushikoshi-Nakayama</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Ryo</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Yamazaki</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Kaneko</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sugano</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Ito</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Saito</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of gummy candy containing ubiquinol on secretion of saliva: a randomized, double-blind, placebo-controlled parallel-group comparative study and an in vitro study</article-title>
                  <source>PloS One</source>
                  <year>2019</year>
                  <volume>14</volume>
                  <issue>4</issue>
                  <fpage>e0214495</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0214495</pub-id>
                  <?supplied-pmid 30943227?>
                  <pub-id pub-id-type="pmid">30943227</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van der Meij</surname>
                      <given-names>EH</given-names>
                    </name>
                    <name>
                      <surname>van der Waal</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications</article-title>
                  <source>J Oral Pathol Med</source>
                  <year>2003</year>
                  <volume>32</volume>
                  <fpage>507</fpage>
                  <lpage>512</lpage>
                  <pub-id pub-id-type="doi">10.1034/j.1600-0714.2003.00125.x</pub-id>
                  <?supplied-pmid 12969224?>
                  <pub-id pub-id-type="pmid">12969224</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Warnakulasuriya</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kujan</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Aguirre-Urizar</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Bagan</surname>
                      <given-names>JV</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer</article-title>
                  <source>Oral Dis</source>
                  <year>2021</year>
                  <volume>27</volume>
                  <issue>8</issue>
                  <fpage>1862</fpage>
                  <lpage>1880</lpage>
                  <pub-id pub-id-type="doi">10.1111/odi.13704</pub-id>
                  <?supplied-pmid 33128420?>
                  <pub-id pub-id-type="pmid">33128420</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yadav</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Priyadarshi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Keshri</surname>
                      <given-names>GK</given-names>
                    </name>
                    <name>
                      <surname>Verma</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Superpulsed 904 nm laser photobiomodulation combined with coenzyme Q10 synergistically augment burn wound healing</article-title>
                  <source>J Photochem Photobiol</source>
                  <year>2021</year>
                  <volume>7</volume>
                  <fpage>100053</fpage>
                  <pub-id pub-id-type="doi">10.1111/phpp.12538</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <mixed-citation publication-type="other">Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. StatPearls Publishing: Treasure Island (FL); 2022.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
